Prime Medicine announced Monday morning that it is cutting its pipeline, and it signed a T cell therapy partnership with ...

Roche is spending $850 million upfront to buy Regor Pharmaceuticals’ suite of next-generation CDK inhibitors as it doubles ...

As other young radiopharmaceutical companies get acquired by drugmakers, Boston-based Aktis Oncology wants to become one of ...

Johnson & Johnson and Legend Biotech's CAR-T cell therapy Carvykti reduced the risk of death by 45% compared to standard of ...

The federal government renewed its threats to Johnson & Johnson on Friday over the company’s proposal to change how some ...

Novo Nordisk has told government and global nonprofits that it plans to significantly downsize its manufacturing of some of ...

WeightWatchers said Friday that its CEO Sima Sistani, who shifted the weight loss giant’s strategy to prescribing obesity ...

The biggest drug driving Sanofi’s and Regeneron’s businesses is about to get a bit bigger. On Friday, the FDA approved ...

Travere Therapeutics said there is a “voluntary pause” in recruitment to its Phase 3 study in a rare, inherited disorder due ...

Cassava Sciences and two of its former executives have reached a resolution with the SEC over charges for “misleading” ...

While the worst of the funding slump for digital health startups since the lofty highs of the pandemic seems to be drawing to ...

What makes a great biotech startup? Every year, the Endpoints 11 awards try to answer that question. We've spent the last ...